NCT07673380 Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City
| NCT ID | NCT07673380 |
| Status | Recruiting |
| Phase | Phase 2 |
| Sponsor | Washington University School of Medicine |
| Condition | Opioid Use |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-08-31 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
In Phase 2, researchers evaluate early signs of effectiveness. You may be randomized to receive the active treatment or a comparator. Monitoring continues closely.
This trial targets 300 participants in total. It began in 2025-08-31 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The sequential trial compares recovery and mHealth engagement outcomes among Black participants who participated in the mHealth intervention uMAT-R or uMAT-R + enhanced community engagement. The mHealth intervention seeks to support people in various stages of recovery who are also seeking other forms of substance use treatment. Participants are recruited from community-based substance use treatment facilities and recovery services. Participants must be adults who have or are currently using opioids and/or stimulants.
Eligibility Criteria
Inclusion Criteria: * Have a history of opioid and/or stimulant use * Identify as Black and/or African American * Seek treatment at local substance use treatment centers * Fluent in English * U.S. resident * 18 years of age or older at the time of data collection. Exclusion Criteria: * Self-reported cognitive impairment that would limit ability to participate in research.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07673380 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Opioid Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07673380 trial and what does that mean for participants?
Phase 2 trials evaluate whether the treatment shows signs of effectiveness while continuing to monitor safety. More participants are enrolled than in Phase 1 to help refine the treatment protocol.
Is NCT07673380 currently recruiting?
Yes, NCT07673380 is actively recruiting participants. Contact the research team at szlyk@wustl.edu for enrollment information.
Where is the NCT07673380 trial being conducted?
This trial is being conducted at St Louis, United States.
Who is sponsoring the NCT07673380 clinical trial?
NCT07673380 is sponsored by Washington University School of Medicine. The trial plans to enroll 300 participants.